Stephen P. Harrington
President chez SPH Investments, Inc.
Postes actifs de Stephen P. Harrington
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPH Investments, Inc. | President | 01/01/1992 | - |
| SPH Equities, Inc. | President | 15/10/2010 | - |
Historique de carrière de Stephen P. Harrington
Anciens postes connus de Stephen P. Harrington
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Zone Mining Ltd.
 Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Président | 01/01/2007 | 01/01/2007 |
| Directeur Financier/CFO | 01/01/2007 | 01/01/2007 | |
| President | - | 01/01/2007 | |
| Secrétaire Général | 01/01/2007 | 01/01/2007 | |
| Treasurer | 01/01/2007 | 01/01/2007 | |
| Touchstone Resources USA, Inc. | Président | 01/08/2005 | 01/08/2005 |
| President | - | 01/08/2005 | |
| Secrétaire Général | 01/08/2005 | 01/08/2005 | |
| Treasurer | 01/08/2005 | 01/08/2005 | |
| ENDEAVOUR INTERNATIONAL CORPORATION | Directeur Général | 01/10/2001 | 01/02/2004 |
| Président | 01/10/2001 | 01/02/2004 | |
| RADIANT LOGISTICS, INC. | Directeur/Membre du Conseil | 26/10/2007 | - |
| Independent Dir/Board Member | 26/10/2007 | - | |
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Directeur/Membre du Conseil | - | - |
iCarbon Corp.
 iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Directeur/Membre du Conseil | - | - |
Formation de Stephen P. Harrington
| Yale University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| President | 4 |
| Chairman | 3 |
| Director/Board Member | 3 |
Sectorielle
| Non-Energy Minerals | 3 |
| Energy Minerals | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RADIANT LOGISTICS, INC. | Transportation |
| Entreprise privées | 7 |
|---|---|
Zone Mining Ltd.
Zone Mining Ltd. Other Metals/MineralsNon-Energy Minerals Zone Mining Ltd. engaged in precious metals and jewels mining industry. The company was founded on January 31, 2005 and was headquartered in Bala Cynwyd, PA. | Non-Energy Minerals |
| Touchstone Resources USA, Inc. | Energy Minerals |
Endeavour International Corp.
 Endeavour International Corp. Oil & Gas ProductionEnergy Minerals Endeavour International Corp. was engaged in exploration and development of oil and gas reserves. The company was founded by William L. Transier and John N. Seitz and was headquartered in Houston, TX. | Energy Minerals |
| SPH Investments, Inc. | |
| SPH Equities, Inc. | |
iCarbon Corp.
iCarbon Corp. Other Metals/MineralsNon-Energy Minerals iCarbon Corp. mines and manufactures natural and synthetic graphite and carbon-based materials. The private company is based in Delano, PA and has subsidiaries in Canada, United States, and China. James E. Olive has been the CEO of the company since 2006. | Non-Energy Minerals |
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
- Bourse
- Insiders
- Stephen P. Harrington
- Expérience
